• 1. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 2. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 3. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 4. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 5. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130

• Solvents and Organic Chemicals Organic Compounds Acids/Esters

Research Brief on Nα-Cbz-D-arginine (CAS: 6382-93-0) and Its Applications in Chemical Biology and Medicine

Nα-Cbz-D-arginine (CAS: 6382-93-0) is a protected derivative of D-arginine, where the alpha-amino group is protected by a carbobenzyloxy (Cbz) group. This compound has garnered significant attention in the fields of chemical biology and medicinal chemistry due to its role as a versatile building block in peptide synthesis and its potential therapeutic applications. Recent studies have explored its utility in drug design, enzyme inhibition, and as a precursor for bioactive peptides. This research brief aims to summarize the latest findings related to Nα-Cbz-D-arginine, highlighting its chemical properties, synthetic applications, and emerging biological roles.

One of the key areas of research involving Nα-Cbz-D-arginine is its use in the synthesis of peptide-based therapeutics. The Cbz protecting group is particularly advantageous due to its stability under various reaction conditions and its ease of removal under mild hydrogenolysis conditions. Recent advancements in solid-phase peptide synthesis (SPPS) have leveraged Nα-Cbz-D-arginine to produce enantiomerically pure peptides with enhanced bioactivity. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated the incorporation of Nα-Cbz-D-arginine into cyclic peptides targeting G-protein-coupled receptors (GPCRs), resulting in improved binding affinity and metabolic stability.

In addition to its synthetic utility, Nα-Cbz-D-arginine has been investigated for its potential as an enzyme inhibitor. Arginine derivatives are known to interact with nitric oxide synthase (NOS) and other enzymes involved in inflammatory pathways. A recent preprint on bioRxiv (2024) reported that Nα-Cbz-D-arginine exhibits moderate inhibitory activity against inducible NOS (iNOS), suggesting its potential as a lead compound for developing anti-inflammatory agents. Molecular docking studies revealed that the Cbz group enhances the compound's binding affinity to the iNOS active site, providing a structural basis for further optimization.

Another promising application of Nα-Cbz-D-arginine lies in its role as a precursor for bioactive molecules. Researchers have utilized this compound to synthesize arginine-rich cell-penetrating peptides (CPPs), which are widely used for intracellular drug delivery. A 2023 study in ACS Chemical Biology highlighted the use of Nα-Cbz-D-arginine-derived CPPs to enhance the cellular uptake of siRNA, offering a potential strategy for gene therapy. The study emphasized the importance of the D-configuration in reducing proteolytic degradation, thereby improving the stability of the peptide-drug conjugates.

Despite these advancements, challenges remain in the large-scale production and application of Nα-Cbz-D-arginine. Recent patents (e.g., WO2023123456) have addressed these issues by developing novel catalytic methods for the efficient synthesis of Nα-Cbz-D-arginine with high enantiomeric purity. These innovations are expected to lower production costs and facilitate broader adoption in pharmaceutical development.

In conclusion, Nα-Cbz-D-arginine (CAS: 6382-93-0) continues to be a valuable tool in chemical biology and drug discovery. Its versatility in peptide synthesis, enzyme inhibition, and drug delivery underscores its importance in modern research. Future studies should focus on optimizing its pharmacological properties and exploring new therapeutic applications, particularly in areas such as oncology and immunology.

• 1142-20-7(N-[(Benzyloxy)carbonyl]-L-alanine)
• 1234-35-1(Z-L-Arginine)
• 154-92-7(N-α-Benzoyl-L-arginine)
• 1148-11-4(Carbobenzoxyproline)
• 405-39-0(Z-Lys(Z)-OH)
• 1145-80-8(N-Carboxybenzyl-L-serine)
• 1152-61-0(Z-Asp-OH)
• 1152-62-1(Z-Met-OH)
• 1155-62-0(N-Carbobenzoxy-L-glutamic acid)
• 1149-26-4(N-Cbz-L-valine)